Novartis Bioventures Ltd 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:30 pm Sale |
2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novartis Bioventures Ltd | 476,085 1.800% |
-1,991,875 (-80.71%) |
Filing |
| 2021-02-01 3:50 pm Sale |
2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX |
Novartis Bioventures Ltd | 2,467,960 9.890% |
-1,075,107 (-30.34%) |
Filing |